Search

everythinglearnresearchcommunity

for

Search:↓

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Biofibre hair implant is a safe, effective treatment for baldness with 95% patient satisfaction.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

The flap advancement technique effectively treats severe scalp skin conditions, preserving hair and improving appearance.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Male pattern baldness affects social interactions and mental health, and while treatments are being explored, hair transplants are currently the most effective solution.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Photobiomodulation improves the quality of life for people with hair loss.

Ayurvedic treatments showed promise in treating premature graying of hair without harmful effects.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.